Coronary sinus retropefusion: Can forward progress still be achieved by using a backward technique?

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 6, 2004, Pages 1549-1552

  Lazar, Harold L ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; AORTA BALLOON; ARTIFICIAL HEART PACEMAKER; BALLOON CATHETER; CARDIOPLEGIA; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY SINUS; CORONARY SINUS RETROPERFUSION; CORONARY STENT; EDITORIAL; FEMORAL ARTERY; HEART CATHETERIZATION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INTERNAL JUGULAR VEIN; META ANALYSIS; PATIENT MONITORING; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRESSURE CONTROLLED INTERMITTENT CORONARY SINUS OCCLUSION; PRIORITY JOURNAL; SYNCHRONIZED RETROPERFUSION; SYSTEMATIC REVIEW; TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; ANIMAL; CORONARY ARTERY OBSTRUCTION; DISEASE MODEL; DOG; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HOSPITALIZATION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOTE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERFUSION; PHYSIOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SWINE;

ANGIOPLASTY, BALLOON; ANIMALS; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; DOGS; HEMODYNAMIC PROCESSES; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; PERFUSION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SWINE;

EID: 2642587464     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.02.010     Document Type: Editorial

References (17)

1. Syeda B, Schukro C, Heinze G, Modaressi K, Glogar D, Maurer G, et al. The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg. 2004;127:1703-12.
2. Lazar HL, Khoury T, Rivers S. Improved distribution of cardioplegia with pressure-controlled intermittent coronary sinus occlusion. Ann Thorac Surg. 1988;46:202-7.
3. Lazar HL, Rajaii A, Roberts AJ. Reversal of reperfusion injury after ischemic arrest with pressure-controlled intermittent coronary sinus occlusion. J Thorac Cardiovasc Surg. 1988;95:637-42.
4. Lazar HL, Haan CK, Yang X, Rivers S, Bernard S, Shemin RJ. Reduction of infarct size with coronary venous retroperfusion. Circulation. 1992;86(suppl 11):11352-7.
5. Lazar HL, Treanor P, Rivers S, Bernard S, Shemin RJ. Combining percutaneous bypass with coronary retroperfusion limits myocardial necrosis. Ann Thorac Surg. 1995;59:373-8.
6. Lazar HL, Yang XM, Rivers S, Treanor P, Bernard S, Shemin RJ. Retroperfusion and balloon support to improve coronary revascularization. J Cardiovasc Surg. 1992;33:538-44.
7. Mohl W, Simon P, Neumann F, Schreiner W, Punzengruber C. Clinical evaluation of pressure-controlled intermittent coronary sinus occlusions: randomized trial during coronary artery surgery. Ann Thorac Surg. 1988;46:192-201.
8. Hatori N, Miyasaki A, Tadokoro H. Beneficial effects of coronary venous retroinfusion of superoxide dismutase and catalase on reperfusion arrhythmias, myocardial function and infarct size in dogs. J Cardiovasc Pharmacol. 1989;14:396-404.
9. Karagueuzian HS, Ohta M, Drury SK. Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarcfion. J Am Coll Cardiol. 1986;7:551-63.
10. Kobayashi S, Tadokoro H, Wakida Y, et al. Coronary venous retroinfusion of deferoxamine reduces infarct size in pigs. J Am Coll Cardiol. 1991;18:621-7.
11. Miyazaki A, Tadokoro H, Drury JK, Ryden L, Haendchen RV, Corday E. Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: a unique and effective approach to coronary artery thrombolysis. J Am Coll Cardiol. 1991;18:613-20.
12. Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung and Blood Institute Registries. Circulation. 2000;102:2945-51.
13. Lazar HL, Bao Y, Lancaster D, Shapira OM, Aldea GS, Shemin RJ. Favorable impact of stents after emergent coronary artery bypass for failed angioplasty. Ann Thorac Surg. 1999;68:1644-7.
14. Suryapranata H, Vanthof AW, Hooorntje JC, de Boer MJ, Zoslstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation. 1998;97:2502-5.
15. Barron HV, Rundle A, Gurwitz J, Tiefenbrunn A. Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2. Cardiol Rev. 1999;7:156-60.
16. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial. Circulation. 1999;100:14-20.
17. Faxon DP, Jacobs AK, McSweeney SM. Coronary sinus assessment of left ventricular pressure in man. In: Mohl W, Wolner E, Glogar D, editors. The coronary sinus. New York: Springer-Verlag; 1984. p. 424-9.